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Abstract
Hepatocyte growth factor (HGF) has been shown to be indispensable for liver regeneration because it serves as a main
mitogenic stimulus driving hepatocytes toward proliferation. We hypothesized that ablating HGF in adult mice would have
a negative effect on the ability of hepatocytes to regenerate. Deletion of the HGF gene was achieved by inducing systemic
recombination in mice lacking exon 5 of HGF and carrying the Mx1-cre or Cre-ERT transgene. Analysis of liver genomic DNA
from animals 10 days after treatment showed that a majority (70–80%) of alleles underwent cre-induced genetic
recombination. Intriguingly, however, analysis by RT-PCR showed the continued presence of both unrecombined and
recombined forms of HGF mRNA after treatment. Separation of liver cell populations into hepatocytes and non-
parenchymal cells showed equal recombination of genomic HGF in both cell types. The presence of the unrecombined form
of HGF mRNA persisted in the liver in significant amounts even after partial hepatectomy (PH), which correlated with
insignificant changes in HGF protein and hepatocyte proliferation. The amount of HGF produced by stellate cells in culture
was indirectly proportional to the concentration of HGF, suggesting that a decrease in HGF may induce de novo synthesis of
HGF from cells with residual unrecombined alleles. Carbon tetrachloride (CCl4)-induced regeneration resulted in a
substantial decrease in preexisting HGF mRNA and protein, and subsequent PH led to a delayed regenerative response.
Thus, HGF mRNA persists in the liver even after genetic recombination affecting most cells; however, PH subsequent to CCl4
treatment is associated with a decrease in both HGF mRNA and protein and results in compromised liver regeneration,
validating an important role of this mitogen in hepatic growth.
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Introduction
The partial hepatectomy (PH) model, in which two-thirds of the
rat or mouse liver is removed and the remaining lobes enlarge to
restore the original liver mass, is an ideal environment to study
organ regeneration and controlled growth after injury [1,2]. The
hallmark of liver regeneration is proliferation of adult hepatic cell
types, including hepatocytes, biliary epithelial cells, endothelial
cells, and hepatic stellate cells (HSCs) [1]. The first peak of DNA
synthesis occurs in hepatocytes around 24 hours in the rat and
approximately 36 hours in the mouse [2]. Cell proliferation and
regeneration is tightly regulated by a series of cell signaling
pathways and cascades that are activated immediately after
resection. One of these is the hepatocyte growth factor (HGF)/
Met pathway.
HGF is a pleiotropic growth factor that has been shown to be
essential for liver regeneration because it serves as the main
mitogenic stimulus driving hepatocytes toward proliferation [1,2].
Within minutes after PH, HGF is converted by urokinase
plasminogen activator (uPA) to its active form, causing a 17-fold
increase in circulating levels of HGF as early as 2 hours after PH
[3]. Once cleaved and activated, HGF then activates its receptor,
Met, within 30–60 minutes after PH [4], initiating a signaling
cascade that results in activation of STAT3, PI3K, and Akt [5,6].
Pre-existing stores of HGF are rapidly depleted and are replaced
by HSCs and endothelial cells, which synthesize new HGF [7,8,9].
Thus, HGF activation and utilization are crucial events for liver
regeneration and provide an early and sustained signal for
hepatocyte proliferation [10].
Systemic deletion of HGF causes mid-gestational embryonic
lethality due to a defect in placental organogenesis [11]. These
mice also have arrested liver development, confirming its essential
role in hepatic morphogenesis [12]. Deletion of the HGF receptor
Met also results in embryonic lethality, and liver-specific
elimination of Met is associated with an impaired or absent
regenerative response [13,14,15]. However, discrepancies in post-
survival surgery make it difficult to determine whether HGF/Met
signaling during regeneration functions primarily to facilitate
hepatocyte survival or mitogenesis [16]. Previous work in our
laboratory has demonstrated lack of suppression of hepatocyte
proliferation after in vivo injection of short hairpin RNA
sequences against HGF, in view of the fact that there are high
concentrations of HGF in the ambient environment of hepatocytes
[17]. Therefore, the effect of long-term or chronic suppression of
HGF in liver regeneration is unknown.
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Recently, Phaneuf et al. generated a mouse with loxP sites
flanking exon 5 of the HGF gene (HGFex.5 flox) [18]. No
apparent phenotypic differences were observed after recombina-
tion, and the proliferative capacity of hepatocytes was only mildly
inhibited when these HGF-deleted animals were challenged with
carbon tetrachloride (CCl4), a hepatotoxin that causes tissue
injury and inflammation resulting in cell death. In order to
elucidate the role of HGF in liver homeostasis as well as assess
the effect of deleting HGF during surgically-induced liver
regeneration, we bred homozygous HGFex.5 flox mice to mice
transgenic for either Mx1-cre or Cre-ERT and then induced cre-
mediated recombination. This method allows for rapid and
temporal gene inactivation in adult tissues (with Mx1-cre being
particularly effective in liver and hematopoietic organs) [19,20].
We demonstrate that despite genomic recombination and
deletion of HGF exon 5, full-length HGF mRNA and protein
persist in the liver. However, administration of CCl4 followed by
PH depletes this mRNA, causing a diminished regenerative
response in mice lacking HGF.
Materials and Methods
Ethics Statement
All animal experiments were performed under the guidelines of
the National Institutes of Health and the Institutional Animal Use
and Care Committee at the University of Pittsburgh. The studies
performed in the current report were approved by the Institutional
Animal Use and Care Committee at the University of Pittsburgh
(protocol #1105844B-4).
Animals, Induction of Genetic Recombination, CCl4
Treatment, and PH
A conditional knockout of HGF was generated by breeding
homozygous HGF-floxed (HGFex.5 flox) mice (as described
previously [18]) to either interferon-inducible Mx1-cre mice or
tamoxifen-inducible cre (Cre-ERT) mice (all on a C57BL/6
background); the resulting mice had the genotype HGFex.5 flox;
Cre+/2 (Figure 1A).
Induction of genetic recombination was achieved by intraper-
itoneal (i.p.) injection of either 100 ml of 10 mg/ml tamoxifen (or
corn oil) once daily for 5 days (for the Cre-ERT mice), or 250 ml of
1 mg/ml polyinosinic:polycytidylic ribonucleic acid (pI:pC) (or
phosphate buffered saline (PBS)) three times at 2-day intervals (for
the Mx1-cre mice). Animals in all conditions were sacrificed
beginning at 10 days after the final injection.
For all experiments, homozygous HGFex.5 flox mice between the
ages of 2.5 and 6 months old were used, with equal distribution of
males and females in all experimental conditions. Experiments
were performed with age- and sex-matched littermates. For more
detailed analysis of animal numbers, see Table 1.
To address the role of HGF in liver regeneration, mice were
divided into three experimental groups: partial hepatectomy (PH),
carbon tetrachloride (CCl4), and CCl4 followed by PH. In the first
group, HGFex.5 flox; Mx1-Cre+/2 mice treated with pI:pC and
HGFex.5 flox; Cre-ERT+/2 mice treated with tamoxifen (as well as
vehicle controls for both genotypes) were anesthetized with
Isoflurane (Baxter, IL) and subjected to PH by resecting the
median and left lateral lobes [4]. In the second group, HGFex.5 flox;
Mx1-Cre+/2mice treated with pI:pC and HGFex.5 flox; Cre-ERT+/
2 mice treated with tamoxifen (as well as vehicle controls for both
genotypes) were administered CCl4 i.p. at a dose of 1 ml/g of body
weight (which has been shown previously to induce liver
regeneration [21]) 1 month after induction of recombination and
allowed to recover for at least 1 week before sacrifice. In the third
group, HGFex.5 flox; Cre-ERT+/2 mice were treated with
CCl4$10 days after a treatment regimen of either tamoxifen or
vehicle control, followed by PH 1 month after CCl4. In all groups,
livers were harvested for DNA, RNA, and protein as described
below.
Primary Rat Hepatocyte and Non-parenchymal Cell (NPC)
Isolation
A single-cell suspension of hepatocytes and NPCs was obtained
from homozygous HGFex.5 flox; Cre+/2 mice treated 10 days prior
with either PBS or p(I):p(C) using a modified calcium two-step
collagenase perfusion technique [22]. Hepatocytes were separated
from NPCs by low-speed centrifugation (50 g, 5 minutes, 4uC).
The resulting supernatant was centrifuged at 500 g for 10 minutes
at 4uC to isolate NPCs. Cells were harvested for DNA, RNA, and
protein as described below.
HSC-T6 Cultures and HGF Treatment
HSC-T6 cells (an immortalized rat liver HSC line [23]) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum at 37uC in 5% CO2 and then
treated with varying concentrations of HGF for 48 hours. Cells
were harvested for protein and RNA as described below.
DNA Extraction and Genomic Polymerase Chain Reaction
(PCR)
DNA was obtained from the livers of sacrificed mice using
phenol/chloroform extraction. PCR was performed in the
presence of DMSO and betaine using the following primers,
which were designed to detect the wild-type (900 bp), floxed
(1200 bp), and recombined (200 bp) forms of HGF genomic
DNA:
Forward: 59 – TGTGACCCTGGATCATCAGTGTAA –39.
Reverse: 59 – CGATGTAAATATATGATATGCAAGA –39.
PCR amplification was carried out as follows: initial denatur-
ation at 94uC for 5 minutes, followed by 35 cycles of denaturation
at 94uC for 20 seconds, annealing at 55uC for 30 seconds,
extension at 72uC for 1 minute, and 10 minutes of final elongation
at 72uC. Samples were run on an agarose gel and visualized using
AlphaImager Mini (ProteinSimple, Santa Clara, CA).
mRNA and RT-PCR
mRNA was isolated and purified from frozen livers using RNA-
Bee (Tel-Test, Friendswood, TX). Two mg total RNA per sample
was treated with DNase and used for reverse transcription in a
20 ml reaction buffer with random primers and Superscript III
(Invitrogen) to generate first-strand cDNA.
PCR was carried out using the Amplitaq Gold kit (Applied
Biosystems, Foster City, CA), dNTPs, and the following primers
for mouse HGF, which were selected to produce a 266 bp wild-
type (unrecombined) product as well as a 123 bp deleted
(recombined) product:
Forward: 59 – CATTGGTAAAGGAGGCAGCTATAAA –39.
Reverse: 59 – TTTCACCATTGCAGGTCATGC –39.
PCR amplification was carried out as follows: initial denatur-
ation at 94uC for 12 minutes, followed by 28 cycles of denaturation
at 94uC for 1 minute, annealing at 55uC for 45 seconds, extension
at 72uC for 45 seconds, and 10 minutes of final elongation at
72uC. Samples were run on an agarose gel and visualized using
AlphaImager Mini (ProteinSimple, Santa Clara, CA).
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Real-time PCR
Quantitative expression levels of unrecombined HGF mRNA
were determined by real-time PCR using SYBR green and the
following primers for detection of full-length HGF:
Forward: 59 – CATTGGTAAAGGAGGCAGCTATAAA –39.
Reverse: 59 – GGATTTCGACAGTAGTTTTCCTGTAGG –
39.
Reverse-transcribed samples were amplified in parallel on an
ABI StepOnePlus instrument (Applied Biosystems). The standard
conditions for real-time PCR were as follows: 2 minutes at 50uC,
10 minutes at 95uC followed by 40 cycles of 15 seconds
denaturation at 95uC, and elongation at 60uC for 1 minute. Each
sample was run in duplicate. Expression levels of HGF were
normalized relative to expression of cyclophilin in each sample.
Gene expression was calculated by using the 2(2DDCt) method,
which was derived from average Ct and expressed as fold change
or percent expression of control. Data represent pooled samples
from n$3 animals per genotype per time point, and real-time
PCR was repeated at least twice for consistency. Representative
assays are shown. For the in vitro HSC-T6 assay, triplicate
samples were run in duplicate and average 2(2DDCt) values are
shown.
Protein Extraction, Immunoprecipitation, and Western
Blotting
Whole-cell lysates from mouse livers or cell lysates from cultured
hepatocytes or NPCs were prepared by homogenization using
RIPA buffer (9.1 mmol/L dibasic sodium phosphate, 1.7 mmol/L
monobasic sodium phosphate, 150 mmol/L sodium chloride, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dode-
Figure 1. Persistence of unrecombined HGF mRNA and protein in the livers of HGFex.5 flox; Cre+/2 mice after genomic
recombination. (A) Schematic of the targeting strategy for conditional inactivation of the gene for HGF (top). Cre-mediated excision of the floxed
HGF allele (middle) leads to the generation of a recombined allele (bottom) lacking exon 5. (B) Successful genomic deletion of HGF exon 5 after
induction of recombination, as shown by PCR. Top - HGFex.5 flox;Cre-ERT mice; bottom - HGFex.5 flox;Mx1-cre mice. (C) RT-PCR shows the presence of
both recombined and unrecombined HGF mRNA in KO livers. (D) WB for HGF in control and HGF KO livers shows no differences after recombination.
Ponceau represents loading control.
doi:10.1371/journal.pone.0059836.g001
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cylsulfate [pH adjusted to 7.4]) containing Halt protease inhibitor
cocktail (Pierce, Rockford, IL). The concentration of the protein in
all lysates was determined by the bicinchoninic acid assay using
BSA as a standard.
For immunoprecipitation (IP) studies, 500 mg of cell lysate
(prepared in RIPA buffer in the presence of inhibitors) was
precleared with mouse IgG together with Protein A/G agarose for
30 minutes at 4uC. After centrifugation, the supernatants were
incubated with 20 mg Met antibody (Cell Signaling, Danvers, MA)
overnight at 4uC. The next day, samples were incubated with
Protein A/G agarose for 1 hour at 4uC. Pellets were collected,
washed in PBS containing inhibitors, resuspended in loading
buffer, and subjected to electrophoresis, as described below.
Fifty mg of protein from cell or liver lysate or 15–20 ml of eluate
from IP studies was subjected to electrophoresis on 7.5% or 4–
12% precast sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) gels using the either the mini-PROTEAN
electrophoresis module assembly (Biorad, Hercules, CA) or the
Nu-PAGE System (Invitrogen, Carlsbad, CA), followed by transfer
to Immobilon-PVDF membranes (Millipore, Bedford, MA).
Membranes were stained with Ponceau-S solution to confirm
equal loading and then blocked in either 5% nonfat dry milk or
5% BSA in blotto solution (Tris-buffered saline with Tween 20),
followed by incubation with primary antibody diluted in 5% milk/
blotto or 5% BSA/blotto overnight. Membranes were washed and
incubated in horseradish-peroxidase conjugated goat anti-mouse
(1:25,000) and donkey anti-rabbit (1:40,000) secondary antibodies
(Chemicon, Temecula, CA) for 1 hour followed by washing.
Proteins were detected by Super-Signal West Pico Chemilumi-
nescent Substrate (Pierce) and visualized by autoradiography.
Primary antibodies used in this study were against HGF (1:500,
abcam, Boston, MA), Met (1:1000) and phosphorylated-Met
(Tyr1234/1235; 1:1000) (Cell Signaling), b-actin (1:5000, Chemi-
con), glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:500,
Santa Cruz Biotechnology, Santa Cruz, CA) and proliferating cell
nuclear antigen (PCNA; 1:200, Santa Cruz). Blots were stripped
with Restore buffer (Pierce) for 10 minutes before re-probing.
Immunohistochemistry
Immunohistochemistry was performed on mouse liver tissues
fixed in 10% formalin, embedded in paraffin, and then sectioned
at 4 mm onto Superfrost Plus glass slides. Sections were
microwaved in either citrate buffer, ZnSO4, or antigen retrieval
solution (Dako, Carpinteria, CA), pretreated with 3% H2O2 to
eliminate endogenous peroxidases, and blocked using Ultra V
Block (Fisher Scientific, Pittsburgh, PA). Primary antibodies used
for this project were against Ki67 (1:200; Fisher), PCNA (1:4000;
Dako), and HGF (1:200; abcam). Secondary antibodies were
biotinylated donkey anti-mouse and donkey anti-rabbit (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA), both used
at a 1:500 dilution. Immunohistochemistry was performed using
the Vectastain ABC Elite kit, developed using DAB (Vector
Laboratories, Inc., Burlingame, CA), and counterstained with
hematoxylin.
Statistical Analysis
All experiments were performed three or more times. Repre-
sentative data from experiments is presented. Autoradiographs of
some western blots were scanned and subjected to densitometry
using ImageJ software. Statistical assessment for significance was
determined using the Student’s t-test (two-tailed). A P value of less
than 0.05 was considered significant (*), and a P value of less than
0.01 was considered highly significant (**).
Results
Despite Genetic Recombination, Unrecombined HGF
mRNA and Protein are Present in the Livers of HGFex.5 flox;
Cre+/2 Mice
Homozygous HGFex.5 flox; Cre+/2 mice treated with a regimen
of either tamoxifen or p(I):p(C) to induce global recombination
were sacrificed after 10 days. Phenotypically, the livers of
recombined animals were indistinguishable from WT livers, with
no apparent changes in liver weight, color, or morphology.
Further, animals followed for more than 8 months subsequent to
deletion of HGF showed no evident phenotype, as assessed by
examination of animal behavior and following complete exami-
nation of tissues by autopsy. Next, portions of the liver were
assessed by PCR to determine the extent of genetic recombination.
The presence of a 200 bp band representing the recombined form
of the gene was confirmation that exon 5 of HGF had been
successfully deleted. Figure 1B shows that in both inducible cre
lines, recombination occurred in approximately 70–80% of DNA.
To analyze the effect of recombination on HGF mRNA, cDNA
was generated from RNA isolated from the livers of these animals.
While Figure 1C shows the presence of a truncated HGF mRNA
transcript in treated mice, the level of unrecombined HGF mRNA
(266 bp) detected in mice that received p(I):p(C) or tamoxifen was
not significantly reduced when compared to control animals.
Furthermore, analysis of HGF protein from control and p(I):p(C)
or tamoxifen treated whole liver lysates by WB showed
heterogeneity between animals with no detectable differences in
Table 1. Genotype and number of mice used in experiments.
Basic Characterization
Genotype Characterization
HGFex.5 flox Mx1-cre Control 4
HGFex.5 flox Mx1-cre KO 11
HGFex.5 flox Cre-ERT Control 5
HGFex.5 flox Cre-ERT KO 10
Partial Hepatectomy (PH)
Genotype D2 D4 D6
Control 3 3 3
HGF KO (Mx-1 cre and Cre-ERT) 4 3 3
Carbon Tetrachloride (CCl4)
Genotype CCl4
HGFex.5 flox Mx1-cre Control 4
HGFex.5 flox Mx1-cre KO 12
HGFex.5 flox Cre-ERT Control 4
HGFex.5 flox Cre-ERT KO 4
PH+CCl4
Genotype D1 D2 D3 D7
Control 3 5 3 3
HGF KO (Cre-ERT KO) 3 3 4 2
doi:10.1371/journal.pone.0059836.t001
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the amount of HGF after recombination (Figure 1D). Thus, in
spite of successful genetic recombination of the floxed HGF alleles,
a significant amount of full-length unrecombined HGF mRNA
and HGF protein persists in the liver.
Recombination Occurs Equally in Both Hepatocytes and
NPCs
AsHGF is produced by non-parenchymal cells, which comprise a
minority subsetof the totalhepaticcellpopulation[24,25],wewanted
to confirm that treatment with agents that induce recombination
targets all liver cell populations non-preferentially. BecauseMx1-cre
and Cre-ERT were indistinguishable in their ability to cause
recombination of the HGF gene in the initial characterization, we
chose to utilizeMx1-cremice for the cell separation experiments.We
isolated hepatocytes and NPC fractions from PBS- and p(I):p(C)-
treatedHGFex.5 flox; Mx1-cre mice and processed the cells for DNA,
RNA, and protein analysis as above. Successful genetic recombina-
tionwas evident in the cell fractions of both hepatocytes andNPCs as
compared to controls (Figure 2A). Analysis of HGF mRNA showed
the presence of recombined HGF mRNA in both hepatocyte and
NPC fractions from p(I):p(C)-treated livers, with NPCs expressing
over four-fold higher levels of HGF than hepatocytes before
recombination; this expression was reduced by half after deletion of
HGF exon 5 (Figure 2B, C). However, as in whole liver, the presence
of unrecombined HGF mRNA is still detectable in both fractions.
ThepresenceofHGFmRNAinthe ‘‘hepatocyte’’ fractionreflects the
standard contamination of such hepatocyte isolates by 3–5% with
non-parenchymal cells. The amount of HGF protein remained
unchanged after p(I):p(C) treatment in both hepatocytes and NPCs,
with HGF expression being primarily localized to the NPC fraction
(Figure 2D). Thus, genetic recombination occurs not only in
hepatocytes, but also in the fraction of hepatic cells that produce
HGF.
PH as a Stand-alone Event Decreases the Amount of
Unrecombined HGF mRNA in Liver; however, HGF
Protein and Proliferation are Unaffected
Despite lack of impact on mRNA and protein, we proceeded to
determine whether genetic deletion of HGF would adversely affect
liver regeneration, and performed PH on HGFex.5 flox Mx1-cre or
Cre-ERT mice treated to induce recombination (hereafter referred
to as HGF KO mice) as well as control HGFex.5 flox untreated
animals. Livers were harvested at days 2, 4, and 6 after PH. In
mouse livers prior to PH, there was a near-complete conversion of
the floxed HGF allele to the recombined fragment in KO mice as
compared to controls (Figure 3A). However, mRNA analysis
shows that the full-length form of HGF persists even after PH
(Figure 3B). In order to detect subtle changes in HGF mRNA
expression that may not be apparent in RT-PCR, we also
performed quantitative real-time PCR, which showed a blunted
expression of full-length HGF as compared to controls, especially
at D6 (Figure 3C). Interestingly, despite a decrease in unrecom-
bined HGF mRNA, HGF protein expression in KO livers is
equivalent to controls at all time points analyzed (Figure 3D).
Finally, Ki67, which identifies cells in the S-phase of the cell cycle,
is also equivalent in both control and HGF KO after PH at all
Figure 2. Recombination occurs in all hepatic cell populations, including those that produce HGF. (A) Separation of hepatic cell
populations from HGFex.5 flox;Mx1-cre mice into hepatocytes and NPCs shows recombination in both after p(I):p(C) treatment as compared to controls.
(B) RT-PCR shows persistence of unrecombined HGF mRNA in both hepatocytes and NPCs. (C) Real-time PCR for full-length HGF mRNA shows a
decrease in HGF in the NPC fraction after p(I):p(C) treatment. (D) WB for HGF in hepatocytes and NPCs shows that the amount of HGF is unchanged in
KOs compared to controls, and is found mainly in the NPC fraction. Ponceau represents loading control.
doi:10.1371/journal.pone.0059836.g002
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time points analyzed (Figure 3E). Thus, despite a depletion of
functional HGF mRNA, liver regeneration is unaffected in HGF
KO mice after PH, consistent with persistent HGF protein.
Production of HGF by HSCs is Regulated by the
Concentration of HGF in Culture
To determine if the population of HSCs containing unrecom-
bined genomic DNA can compensate for an environmental deficit
of HGF by increasing de novo production of full-length HGF, we
tested the reverse - whether HSCs in culture could suppress
production in response to an increase in HGF. HSC-T6 cells
actively suppress HGF mRNA in a dose-dependent manner in
response to concentrations of HGF as low as 10 ng/ml, as shown
in Figure 4A. HGF protein is also decreased upon addition of
HGF to the media (Figure 4B, C). Thus, HSCs are able to regulate
HGF production by sensing homeostatic perturbations in ambient
HGF and responding accordingly.
Figure 3. No change in amount of HGF protein or hepatocyte proliferation in HGF KO mice after PH. (A) Genomic recombination is
present in cre-inducible HGFex.5 flox KO mice at all time points after PH, as assessed by PCR. (B) RT-PCR shows a significant amount of full-length HGF
mRNA remaining in KOs even after PH. (C) The amount of unrecombined HGF is slightly decreased in HGF KO as compared to controls before and
after PH, as assessed by real-time PCR. (D) Comparable amounts of HGF protein in control and HGF KO livers after PH. Ponceau represents loading
control. (E) Proliferation is unaffected in HGF KO mice after PH, as shown by representative images of Ki67 IHC (100X).
doi:10.1371/journal.pone.0059836.g003
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Figure 4. Inverse correlation between the concentration of HGF in culture and production of HGF by HSCs. (A) Real-time PCR for HGF
mRNA shows a dose-dependent decrease in HGF production by HSC-T6 cells in response to increasing concentrations of HGF in culture (*P,0.05;
**P,0.01). (B) HGF protein production by HSC-T6 cells decreases in response to increased HGF, as measured by WB. Actin represents loading control.
(C) Densitometry analysis on representative WB shown in (B).
doi:10.1371/journal.pone.0059836.g004
HGF Knockout Mice Show Delayed Liver Regeneration
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HGF mRNA and Protein are Significantly Decreased in
HGFex.5 flox; Cre+/2 Mice Treated with CCl4 after
Recombination
In view of the results shown in Figure 3B, in an attempt to
deplete the persisting unrecombined HGF mRNA, HGF KO mice
were subjected to CCl4, a hepatotoxin that induces liver damage
and regeneration. Figure 5A shows that HGFex.5 flox; Cre+/2 mice
treated with either p(I):p(C) or tamoxifen to induce recombination
show a greater than 50% decrease in unrecombined HGF mRNA;
however, when these mice were stimulated into liver regeneration
by treatment with CCl4 at 1 month after the cessation of the cre-
inducing protocol, HGF mRNA expression decreases even further
in HGFex.5 flox; Cre-ERT KO livers, to 20% that of controls.
HGFex.5 flox; Mx1-cre livers also show a significant and measurable
decrease in HGF protein expression, as demonstrated by WB
(Figure 5B). Thus, induction of liver regeneration by CCl4 forces
the HGF KO liver to deplete existing stores of unrecombined
HGF mRNA and protein, mandating de novo HGF synthesis in
the liver upon future insults or surgical manipulations.
CCl4 and PH in HGFex.5 flox; Cre-ERT KO Mice Results in
Compromised Liver Regeneration Due to a Decrease in
HGF
Finally, we performed PH on control and HGFex.5 flox; Cre-ERT
KO mice after they had recovered and fully regenerated from the
administration of CCl4, in order to induce de novo synthesis of
truncated, non-functional HGF in KO and thus assess the impact
on liver regeneration. HGF KO mice triggered into liver
regeneration first by CCl4 and (after 1 month) followed by PH
have a 3-fold reduction in HGF mRNA at D1, as compared to
KO mice given PH only, which have a 2-fold decrease (Figure 6A).
Interestingly, the amount of HGF mRNA at D2 in KOs is almost
equivalent to that of controls, suggesting a persistent compensatory
or feedback mechanism. The liver weight to body weight (lw/bw)
ratio in HGF KO mice was significantly less at D2 after PH
(Figure 6B), indicating a defect in regeneration that could result
from a lack of HGF evident at D1. These findings coincided with
fewer numbers of proliferating hepatocytes in HGF KO mice at
D2, as measured by PCNA staining (Figure 6C, D, E). However,
proliferation at D3 and D7 is comparable to WT (data not shown),
Figure 5. Liver regeneration stimulated by CCl4 depletes HGFmRNA and protein in HGF KOmice. (A) CCl4 treatment following genomic
recombination further decreases full-length HGF mRNA, as assessed by real-time PCR. (B) WB shows decreased HGF expression in livers of HGF KO
mice treated with CCl4 in combination with p(I):p(C), as compared to controls or those treated with p(I):p(C) only. Ponceau represents loading control.
doi:10.1371/journal.pone.0059836.g005
HGF Knockout Mice Show Delayed Liver Regeneration
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and all KO mice survive surgery, indicating that deletion of HGF
delays, but does not abolish, liver regeneration.
Analysis of HGF by WB demonstrates a noteworthy decrease in
HGF protein in KOs at D2 as compared to controls (Figure 6E),
which is confirmed by IHC for HGF, which shows sparse and
irregular distribution of HGF expression (Figure 6F). This occurs
despite some persistence of the unrecombined form of HGF
mRNA shown in Fig. 6A. Intriguingly, levels of the HGF receptor
Met were higher in HGF KO livers at D2 after PH (Figure 7A).
However, there was a dramatic decrease in the tyrosine-
phosphorylated (active) form of Met in HGF KOs as assessed by
IP for Met, suggesting that signaling through Met is impaired in
the absence of HGF (Fig. 7B). Thus, depletion of unrecombined
HGF mRNA below a certain level by induction of two sequential
cycles of regeneration through CCl4 and PH finally resulted in
delayed liver regeneration in HGF KO mice.
Discussion
HGF has been implicated as an initiator of liver regeneration
because it is a direct mitogen for hepatocytes in culture, it is the
only hepatocyte mitogen detectable in the plasma after PH, it
activates signal transduction very early after PH, and it can cause
massive hepatic enlargement and hepatocyte DNA synthesis when
injected in mice and rats [4,22,26,27,28,29]. As genetic deletion of
HGF or Met is embryonic lethal, it has thus far not been possible
to study the contribution of HGF/Met signaling to liver
regeneration in the sustained absence of this signaling pathway.
Therefore, we employed the cre-loxP system to ablate HGF in
adult mice.
Although HSCs are the primary source of HGF during liver
regeneration [9], there are two major hurdles to utilizing a stellate
cell-specific knockout. First, the HSC population in the liver is
known to be heterogeneous [30,31], and thus one marker alone is
insufficient to isolate or characterize these cells. Therefore, cre-
mediated deletion using a single stellate cell-specific promoter
would only delete the floxed gene from a subset of stellate cells.
Second, other cell types, such as endothelial cells, are also known
to express HGF in the liver, particularly during liver regeneration
[8,32]. The rationale behind utilizing the global conditional
deletion is to remove HGF from all cell types in the liver in a non-
biased way.
HGF consists of an a-subunit containing four kringle domains
and a b-subunit pseudo-protease domain [33]. Mutations of HGF
lacking the first or second kringle domains are unable to bind to
and activate the Met receptor [34]. Therefore, we utilized a mouse
model in which exon 5 of the HGF gene, which encodes most of
the first kringle domain, was deleted [18]. We demonstrated that
HGF is an essential component of an efficient regenerative
response after PH, and in the absence of this growth factor, liver
regeneration is delayed. However, the results were complicated by
the fact that full-length HGF mRNA and protein were present in
the liver despite efficient recombination of the HGF gene, and
treatment with two sequential regenerative stimuli (CCl4 followed
by PH) was necessary to sufficiently deplete the stores of
unrecombined HGF and create a dependency on de novo
synthesis.
The persistence of full-length HGF mRNA in the liver suggests
two possibilities, either of which may occur: first, that HGF
mRNA is long-lived; and second, that HSCs with unrecombined
mRNA can regulate production of HGF in response to
fluctuations in the amount of HGF present in their environment
and maintain sufficient amounts of HGF mRNA and protein. The
half-life of HGF mRNA has been reported in the literature to be
on the order of minutes to hours rather than days [35,36,37].
However, these measurements were performed in actively
proliferating cells, whereas in normal resting liver, stellate cells
(and hepatocytes, perhaps the most important cell population
recipient of HGF protein) are quiescent and thus would have less
need for rapid turnover of growth factor mRNAs. It is known that
the half-lives of many mRNAs are determined by trans-acting
factors, such as hormones, growth factors, ions, and cytokines,
which can influence mRNA longevity by protecting it from
degradation [38]. Furthermore, mRNA half-life is closely tied to its
Figure 6. Liver regeneration is compromised in HGF KO mice after CCl4 and PH due to a decrease in HGF. (A) Real-time PCR
demonstrates decreased HGF mRNA in HGFex.5 flox; Cre-ERT KO mice treated with both CCl4 and PH as compared to control at D1 after PH. (B) Graph
of liver weight to body weight ratios after CCl4/PH shows a significant decrease in HGF KOs at D2. (*P,0.05) (C) Representative images of PCNA IHC
on livers harvested at D2 after PH in control and HGF KO animals treated with CCl4 (200X) (D) Quantification of PCNA staining shown in (C). A total of
5 fields per liver (n = 3 per condition) were counted. (**P,0.01) (E) WB for HGF and PCNA shows a dramatic decrease in both proteins in HGF KO
animals at D2 after CCl4/PH. Ponceau represents loading control. (F) HGF IHC in control and HGF KO livers harvested at D2 after PH demonstrates
sparse and irregular distribution of HGF protein.
doi:10.1371/journal.pone.0059836.g006
Figure 7. Met expression and activation is altered in HGF KO mice after CCl4 and PH. (A) WB for total Met shows increased expression in
HGF KO animals at D2 after CCl4/PH. GAPDH represents loading control. (B) IP shows that Met is phosphorylated and active in controls but not in HGF
KOs at D2 after CCl4/PH. Successful pulldown of Met is verified, and a non-specific band is used as normalizing control.
doi:10.1371/journal.pone.0059836.g007
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physiological function [39], and since HGF is stored in an inactive
form in the liver extracellular matrix (ECM), it is conceivable that
HGF mRNA turnover in normal liver is low. In support of the
argument for a long half-life for HGF mRNA is the fact that the
amount (or percent of total) of intact unrecombined HGF mRNA
was decreased by two sequential regenerative episodes. However,
we also found that the stellate cell line HSC-T6 was able to
decrease production of HGF in response to increasing concentra-
tions of HGF in media. Others have also shown that HSCs express
Met and can thus respond to HGF [40,41]. Therefore, a small
number of stellate cells with unrecombined mRNA may be able to
respond to low levels of HGF and compensate by producing more
HGF protein. Both of the above mechanisms may contribute to
the preservation of HGF mRNA in KO mice after recombination.
One episode of liver regeneration alone causes a decrease in
residual unrecombined HGF mRNA (Figure 3). This is because
liver regeneration activates synthesis of new HGF, and active
translation of any mRNA typically results in a portion of the
translated mRNA being degraded. Thus, we wanted to use two
consecutive rounds of regeneration – the first to deplete existing
HGF, and the second to force transcription of HGF – in order to
determine the effect of HGF loss on liver regeneration. In view of
operative difficulties in performing two sequential partial hepa-
tectomies, we used pretreatment with CCl4 as the first regener-
ative event to ensure pre-existing stores of HGF are consumed by
CCl4 prior to PH. This would thus create truncated, inactive HGF
protein in the KO during the next cycle of liver regeneration (PH),
as an increasingly larger percentage of HGF would have to be
derived from the truncated mRNA. CCl4-induced liver regener-
ation is not as standardized as that induced by PH due to
confounding factors such as inflammation, injury, and necrosis.
However, a previous study has shown that plasma HGF levels are
prolonged after CCl4 due to enhanced synthesis of HGF, and thus
overall CCl4-mediated liver regeneration requires more HGF
than normal liver regeneration [3]. Indeed, we show that
pretreatment with CCl4 rapidly depletes the unrecombined
preexisting HGF (Figure 5). Our study indicates that inactive
HGF stored in the matrix may be enough to drive hepatocyte
proliferation in HGF KO mice without the need for de novo
synthesis, and only after preexisting stores of HGF are utilized and
depleted does deficient production of HGF compromise liver
regeneration.
Another intriguing observation was the significant increase in
Met receptor expression in HGF KOs 2 days after PH.
Phosphorylation and activation of Met is known to lead to
ubiquitination and subsequent degradation [42], which may
explain the absence of Met in WT livers at D2. Indeed, we found
evident phosphorylation of Met in WTs, while Met activation in
HGF KOs was eliminated, as demonstrated by detection of the
tyrosine-phosphorylated form of Met by IP. Thus, continued
expression of Met in KO may reflect the lack of ongoing HGF
needed to activate this signaling pathway, preventing Met
degradation which occurs after HGF ligation with its receptor
[42].
Inducible inactivation of floxed alleles is an interesting approach
to study the essentiality of growth factors. This is especially true in
the case of HGF/Met signaling, since there is only one receptor for
HGF (i.e. c-Met) and only one ligand for c-Met (i.e. HGF); hence,
the unique one-on-one relationship between these cognate
partners is the only one which is capable of causing uncompen-
sated signaling loss if it were to fail. Our studies, however,
demonstrate the caution required to fully interpret findings with
deletion of growth factors. In the case of HGF, systemic deletion is
embryonic lethal. The phenotypes caused by systemic deletion of
either HGF or Met are identical. Contrary to this, we find that
postnatal deletion of HGF is not associated with any phenotype.
Careful analysis, however, demonstrates that the presence of HGF,
though difficult to eliminate by simple standard genetic manipu-
lation, is important during liver regeneration. This is demonstrable
only after all efforts have been taken to decrease HGF to very low
levels in the ambient environment of the hepatocytes, and in the
absence of these efforts, erroneous conclusions could be drawn.
Overall, the HGF KO mouse gave us the opportunity to gain
further insight into the complexities of the role and regulation of
HGF expression during liver regeneration.
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